Comp Docs Applaud FDA's Opioid Training Initiative

By Michael Whiteley, Eastern Bureau ChiefDoctors involved in publishing the nation's medical treatment guidelines for injured workers are supporting an initiative by the U.S. Food and Drug Administration (FDA) to educate the nation's medical providers on the use of opioids.On Nov. 4, the FDA posted its "Blueprint for Prescriber Continuing Education Program" with a focus on medical providers who prescribe extended-release, long-acting opioids, such as the painkillers oxycodone, sold under the brand name OxyContin, morphine and fentanyl, sold under the brand name Actiq.The FDA said in a ...